期刊文献+

鼻咽癌组织DNA聚合酶β基因突变与EBV感染相关

DNA polymerase β gene mutation in human nasopharyngeal cancer and its relationship with EBV infection
下载PDF
导出
摘要 目的:研究探讨鼻咽癌中DNA聚合酶β(DNA pol-ym erase,βpolβ)的变异情况及与EBV感染有无相关关系.方法:采用RT-PCR法(逆转录-DNA聚合酶链反应)、PCR-SSCP(聚合酶链-单链构象多态性分析)、DNA序列分析法对26例鼻咽癌组织及癌旁组织标本进行polβ基因突变研究.用特异性EBV引物PCR扩增法检测EB病毒,分析出现EBV-PCR阳性与polβ突变及鼻咽癌发生之间的相关性.结果:polβ-SSCP结果显示癌旁组织标本中polβ无突变;26例鼻咽癌组织标本中存在polβ基因变异的有8例,突变率为30.8%.polβ基因变异的鼻咽癌标本测序结果显示:核苷酸序列有多种形式的改变.提取DNA用EBV引物进行扩增,26例鼻咽癌标本中出现阳性的有24例,阳性率为92.3%.结论:首次发现在鼻咽癌中存在多种形式的polβ突变,有polβ突变的病例均有EBV感染. AIM: To study DNA polymerase β (polβ) gene mutation in human nasopharyngeal cancer and its relationship with EBV. METHODS: Twenty-six cases of nasopharyngeal carcinoma tissues and corresponding normal epithelial tissues were collected to study DNA polβ gene mutation with PT-PCR, PCR-SSCP and DNA sequence analyzing techniques. DNA was extracted and amplified with EBV primers and the results were observed and analyzed. RESULTS: polβ gene mutation was detected by SSCP in 8 of the 26 nasopharyngeal cancer tissues (with mutation rate 30.8%) and there was no mutation in juxtacancerous tissues. Many types of mutation were found by DNA sequencing. EBV-DNA positive rate was 92.3%. The results of experiment indicated that the cases of polβ-SSCP abnormal were accompanied with EBV infection. CONCLUSION: There is polβ alternation in human nasopharyngeal carcinoma, which leads to the sequence alternation in amino acid and spatial structure change. These mutations and EBV infection may play an important role in tumor genesis.
出处 《第四军医大学学报》 CAS 北大核心 2005年第19期1790-1791,共2页 Journal of the Fourth Military Medical University
基金 国家自然科学基金(39870287)
关键词 DNA聚合酶Β 鼻咽肿瘤 基因 突变 EB病毒 DNA polymerase β nasopharyngeal neo-plasms gene mutation EBV
  • 相关文献

参考文献8

  • 1Giarnieri E, Mancini R, Pisani T, et al. Msh2, Mlh1, Fhit, p53, Bcl-2, and Bax expression in invasive and in situ squamous cell carcinoma of the uterine cervix[J]. Clin Cancer Res, 2000;6(9):3600-3606.
  • 2Bergoglio V, Pillaire MJ, Wright M, et al. Deregulated DNA polymerase beta induces chromosome instability and tumorigenesis [J]. Cancer Res, 2002;62(12):3511-3514.
  • 3Frechet M, Canitrot Y, Cazaux C, et al. Deregulated DNA polymerase beta strengthens ionizing radiation-induced nucleotidic and chromosomal instabilities[J]. Oncogene, 2002;21(15):2320-2327.
  • 4Hubscher U, Nasheuer HP, Syvaoja JE. Eukaryotic DNA polymerases, a growing family[J]. TIBS, 2000;25(3): 143-147.
  • 5许亮国,杨旭宇,谢鹭,陈曲侯,王珣章,姚开泰.用原位PCR方法检测鼻咽癌组织中的EB病毒[J].中华肿瘤杂志,2000,22(1):17-18. 被引量:6
  • 6Yamada NA, Farber RA. Induction of a low level of microsatellite instability by overexpression of DNA polymerase Beta[J]. Cancer Res, 2002;62(21):6061-6064.
  • 7杨玉芳,丁彦青,石益民,刘换新.嗜上皮细胞特异性启动子ED-L2转基因小鼠的建立[J].第四军医大学学报,2003,24(21):1953-1955. 被引量:4
  • 8曾亮,刘轶平,王海,陶永光,赵晓荣,李嵬,曹亚.EB病毒潜伏膜蛋白1介导鼻咽癌细胞中转录因子Ets-1表达的实验研究[J].中华肿瘤杂志,2004,26(8):454-457. 被引量:5

二级参考文献16

  • 1[1]Sung NS, Edwards RH, Seillier-Moiseiwitsch F, Perkins AG, Zeng Y, Raab-Traub N, Seillier-Moiseiwitsch F, Perkins AG, Zeng Y, Raab-Traub N. Epstein-Barr virus strain variation in nasopharyngeal carcinoma from the endemic and non-endemic regions of China[J]. Int J Cancer, 1998;76(2):207-215.
  • 2[2]Abdulkarim B, Sabri S, Zelenika D, Deutsch E, Frascogna V, Klijanienko J, Vainchenker W, Joab I, Bourhis J. Antiviral agent cidofovir decreases Epstein-Barr virus (EBV) oncoproteins and enhances the radiosensitivity in EBV-related malignancies[J]. Oncogene, 2003;22(15):2260-2271.
  • 3[3]Liebowitz D. Nasopharyngeal carcinoma: The Epstein-Barr virus association[J]. Semin Oncol, 1994;21(3):376-381.
  • 4[4]Herbst H, Dallenbach F, Hummel M, Niedobitek G, Pileri S, Muller-Lantzsch N, Stein H. Epstein-Barr virus latent membrane protein expression in Hodgkin and Reed-Sternberg cells[J]. Proc Natl Acad Sci USA, 1991;88(11):4766-4770.
  • 5[5]Nakagawa H, Wang TC, Zukerberg L, Odze R, Togawa K, May GH, Wilson J, Rustgi AK. The targeting of the cyclin D1 oncogene by an Epstein-Barr virus promoter in transgenic mice causes dysplasia in the tongue, esophagus and forestomach[J]. Oncogene,1997;14(10):1185-1190.
  • 6[6]Jenkins TD, Opitz OG, Okano J, Rustgi AK. Transactivation of the human keratin 4 and Epstein-Barr virus ED-L2 promoters by gut-enriched Kruppel-like factor[J]. J Biol Chem,1998;273(17):10747-10754.
  • 7[7]Jenkins TD, Nakagawa H, Rustgi AK. The keratinocyte-specific Epstein-Barr virus ED-L2 promoter is regulated by phorbol 12-myristate 13-acetate through two cis-regulatory elements containing E-box and Kruppel-like factor motifs[J]. Biol Chem, 1997;272(39):24433-24442.
  • 8[8]Jenkins TD, Mueller A, Odze R, Shahsafaei A, Zukerberg LR, Kent R, Stoner GD, Rustgi AK. Cyclin D1 overexpression combined with N-nitrosomethylbenzylamine increases dysplasia and cellular proliferation in murine esophageal squamous epithelium[J]. Oncogene, 1999;18(1):59-66.
  • 9[9]Mueller A, Odze R, Jenkins TD, Shahsesfaei A, Nakagawa H, Inomoto T, Rustgi AK. A transgenic mouse model with cyclin D1 overexpression results in cell cycle, epidermal growth factor receptor, and p53 abnormalities[J]. Cancer Res, 1997;57(24):5542-5549.
  • 10[10]Opitz OG, Harada H, Suliman Y, Rhoades B, Sharpless NE, Kent R, Kopelovich L, Nakagawa H, Rustgi AK. A mouse model of human oral-esophageal cancer[J]. J Clin Invest, 2002;110(6):761-769.

共引文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部